Sur­geons suc­cess­ful­ly at­tach pig kid­ney to a hu­man for the first time, us­ing tech from Unit­ed's Re­vivi­cor

In a first, re­searchers re­port­ed­ly suc­cess­ful­ly trans­plant­ed a pig kid­ney in­to a hu­man with­out trig­ger­ing an im­me­di­ate im­mune re­sponse this week. And the tech­nol­o­gy came from the biotech Unit­ed Ther­a­peu­tics.

Sur­geons spent three days at­tach­ing the kid­ney to the pa­tient’s blood ves­sels, but when all was said and done, the kid­ney ap­peared to be func­tion­ing nor­mal­ly in ear­ly test­ing, Reuters and the New York Times were among those to re­port. The kid­ney came from a ge­net­i­cal­ly al­tered pig de­vel­oped through Unit­ed’s Re­vivi­cor unit.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER